ReviewOncotarget2018
Anorectal mucosal melanoma.
Review in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed, 99 citations in OpenAlex.
- Primary anorectal malignant melanoma with synchronous hepatic metastases in middle-aged patient: a case report.Journal of surgical case reports · 2026Article
- Comparison of survival outcomes between local excision and radical resection in patients with rectal mucosal melanoma.World journal of surgical oncology · 2026Article
- Detection and surgical intervention in anorectal malignant melanoma: a case report.Journal of medical case reports · 2026Article
- Primary melanoma of the gastrointestinal tract.World journal of gastroenterology · 2026Review
- Consider the unexpected! An overlooked, elusive, rare but dramatic diagnosis: anorectal melanoma.Updates in surgery · 2025Article
- Article
- Early diagnosis and delayed treatment of anorectal melanoma in a 19-year-old female: A case report.International journal of surgery case reports · 2025Article
- Simultaneous malignant peripheral nerve sheath tumour and malignant melanoma of the anorectal region.International cancer conference journal · 2025Article
- Case Report: S100-negative primary anorectal melanoma with elevated Ki67: a case for biology-driven radical resection despite early radiological staging.Frontiers in oncology · 2025Article
- Case Report: Surgical management and prognostic factors in primary anorectal melanoma: a retrospective analysis of nine cases.Frontiers in medicine · 2025Article
- Evaluating Tumor Dynamics Using Circulating Tumor DNA in the Rare Cancer Anorectal Malignant Melanoma: A Report of Two Cases.Surgical case reports · 2025Article
- Small-Bowel Metastatic Melanoma From Primary Mucosal Melanoma of the Anus: A Comprehensive Case Report.ACG case reports journal · 2025Article
- An Interesting Rare Case Report of Primary Amelanotic Melanoma With Distant Metastasis.Cureus · 2024Article
- Article
- Surgical Management of Primary Anorectal Melanoma: Is Less More?Journal of gastrointestinal cancer · 2024Article
- Article
- A nuanced exploration delving into malignant melanomas occurring in unexpected and less common anatomical locations.Journal of family medicine and primary care · 2024Article
- Neoadjuvant ipilimumab plus nivolumab therapy as a potential organ preservation strategy in mucosal melanoma: case report.Frontiers in oncology · 2024Article
- [Anorectal melanoma : Update on clinical presentation, diagnosis and treatment].Dermatologie (Heidelberg, Germany) · 2024Review
- Anorectal mucosal melanoma.Seminars in colon & rectal surgery · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anorectal melanoma is an uncommon and aggressive mucosal melanocytic malignancy. Due to its rarity, the pre-operative diagnosis remains difficult. The first symptoms are non-specific such as anal bleeding, anal mass or pain. Although anorectal melanoma carries a poor prognosis; optimal therapeutics strategies are unclear. Surgical resection remains the mainstay of treatment. The optimal surgical procedure for primary tumours is controversial and can vary from wide local excision or endoscopic mucosal resection (EMR) to an abdomino-perineal resection. A high degree of uncertainly exists regarding the benefit of radiation therapy or chemotherapy. The treatment of advanced melanoma is evolving rapidly with better understanding of the disease biology and immunology. Considerable effort has been devoted to the identification of molecular determinants of response to target therapies and immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.